GlassScriptPhysician profile
Kelly A Ramirez
NPI 1295170116
$1,832.64
in general payments reported to CMS, 2019-2025
13 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2022: $267 · 2023: $946 · 2024: $101 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,165.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $400.14 | 2019 | |
| Abbvie INC. | $394.65 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $350.90 | 2022-2024 | Austedo, Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $221.69 | 2022-2024 | |
| Tg Therapeutics, INC. | $127.69 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $119.04 | 2025 | |
| Celgene Corporation | $46.43 | 2023 | Zeposia |
| Genzyme Corporation | $44.43 | 2022 | |
| Alexion Pharmaceuticals, INC. | $33.72 | 2023 | Ultomiris |
| Argenx US, INC. | $26.84 | 2022 | |
| Neurelis, INC. | $24.87 | 2023 | Valtoco |
| Sumitomo Pharma America, INC. | $23.40 | 2023 | Aptiom |
| Emd Serono, INC. | $18.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.